Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $14 from $18 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results which provided many updates by low visibility remains.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $13 from $16 at Piper Sandler
- Dentsply Sirona Unveils Strategic Plan Amid Q3 Losses
- DENTSPLY SIRONA Faces Challenges Amid Earnings Call Insights
- Dentsply Sirona downgraded to Market Perform from Outperform at William Blair
- DENTSPLY SIRONA: Hold Rating Amid Strategic Investments and Revised Growth Outlook